SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VD's Model Portfolio & Discussion Thread
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Vector1 who wrote (1165)6/12/1997 2:20:00 AM
From: Andrew H   of 9719
 
I read a couple of their press releases. This Bexxar treatment looks extremely promising. Verrry impressive results. I am not familiar with NHL or IDEC's drug. Looks like they are about 1 year away from filing a BLA and from the release, it looks like their only other product is very preclinical. The drug would probably be fast tracked. I don't know the mortality rate for NHL, but this seems like a godsend to those suffering from the disease. Seems like a large market for NHL. Definitely worth putting on the watch list.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News